3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Adenocarcinoma, Follicular
1
Interventions
trametinib
1
spartalizumab
1
pembrolizumab
1
motesanib diphosphate
1
lenvatinib
1
gallium Ga 68 dotatate
1
dabrafenib
1
cediranib
1
Sorafenib
1
Sodium Iodide
1
Lenalidomide
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid cancer, Hurthle cell
×
Sodium Iodide
×
Endocrine
×
Clear all
NCT01398085
2026-05-07
IoN
University College, London
Phase 2/3
Active not recruiting
504 enrolled